Gilead Sciences files quarterly report (10-Q) for the period ended Jun 30, 2026

Gilead Sciences filed its quarterly report on Form 10-Q with the SEC on Aug 6, 2026, 4:13 PM ET, covering the quarter ended Jun 30, 2026. It reports fiscal Q2 2026 results.

• Revenue: $7.80B (+10.2% from $7.08B a year earlier)
• Operating income: −$10.39B (vs $2.47B a year earlier)
• Net income: −$10.50B (vs $1.96B a year earlier)
• Diluted EPS: $-8.45 (vs $1.56 a year earlier)
• Form 10-Q accepted by EDGAR Aug 6, 2026, 4:13 PM ET
• Accession number 0000882095-26-000031

SEC filing 10-Q · accession 0000882095-26-000031 · sec.gov ↗